Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.21 is 75% above its 5-year average of 5.83, around the middle of its 5-year range (1.39–18.42).
As of the fiscal period ended Tuesday, June 30, 2026. 49.16% above its 12-month average of 6.84.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.21.
QUICK RATIO (ACID-TEST)
10.21
QUICK RATIO (ACID-TEST) AVG TTM
6.84
QUICK RATIO (ACID-TEST) AVG 3Y
4.20
QUICK RATIO (ACID-TEST) AVG 5Y
5.83
QUICK RATIO (ACID-TEST) AVG 10Y
3.39
QUICK RATIO (ACID-TEST) AVG 15Y
2.41
QUICK RATIO (ACID-TEST) AVG 20Y
2.31
CURRENT VS TTM AVG
+49.16%
CURRENT VS 3Y AVG
+142.92%
CURRENT VS 5Y AVG
+75.11%
CURRENT VS 10Y AVG
+201.16%
CURRENT VS 15Y AVG
+322.83%
CURRENT VS 20Y AVG
+340.95%
SECTOR MEDIAN · HEALTHCARE
2.85
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+258.15%
vs the sector median at left
Enveric Biosciences, Inc.
Market Cap
$6.76M
Quick Ratio (Acid-Test)
10.21
TTM Avg
6.84
3Y Avg
4.20
5Y Avg
5.83
Market Cap
$6.74M
Quick Ratio (Acid-Test)
16.20
TTM Avg
7.76
3Y Avg
4.60
5Y Avg
3.08
Market Cap
$6.72M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$6.88M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$7.03M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.44M
Quick Ratio (Acid-Test)
N/A
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.05
Market Cap
$6.34M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.44
3Y Avg
2.71
5Y Avg
3.16
Market Cap
$6.10M
Quick Ratio (Acid-Test)
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | $6.76M | 10.21 | 6.84 | 4.20 | 5.83 |
| Aclarion, Inc. (ACON)vs › | $6.74M | 16.20 | 7.76 | 4.60 | 3.08 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 2.61 | 3.40 | 4.86 | 5.09 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | 1.52 | 3.93 | 10.24 | 10.80 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | 45.95 | 58.73 | 40.89 | 40.89 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | 2.00 | 1.31 | 1.05 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 0.93 | 1.44 | 2.71 | 3.16 |
| Femasys Inc. (FEMY)vs › | $6.10M | 0.55 | 1.77 | 4.96 | 6.03 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 17.15 | 11.86 | 7.50 | 9.06 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 119.39 | 100.04 | 53.35 | 40.07 |
Quick Ratio
10.21
Excludes inventory
Current Ratio
10.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.21 |
| 2026-03-31 | 11.66 |
| 2025-12-31 | 5.38 |
| 2025-09-30 | 4.60 |
| 2025-06-30 | 2.38 |
| 2025-03-31 | 4.08 |
| 2024-12-31 | 1.84 |
| 2024-09-30 | 5.19 |
| 2024-06-30 | 8.55 |
| 2024-03-31 | 3.48 |
| 2023-12-31 | 1.53 |
| 2023-09-30 | 1.39 |
| 2023-06-30 | 1.81 |
| 2023-03-31 | 3.34 |
| 2022-12-31 | 4.61 |
| 2022-09-30 | 8.57 |
| 2022-06-30 | 8.33 |
| 2022-03-31 | 10.83 |
| 2021-12-31 | 8.51 |
| 2021-09-30 | 10.30 |
| 2021-06-30 | 18.42 |
| 2021-03-31 | 37.36 |
| 2020-12-31 | 3.35 |
| 2020-09-30 | 0.81 |
| 2020-06-30 | 0.80 |
| 2020-03-31 | 0.61 |
| 2019-12-31 | 0.53 |
| 2019-09-30 | 0.65 |
| 2019-06-30 | 0.76 |
| 2019-03-31 | 0.78 |
| 2018-12-31 | 0.68 |
| 2018-09-30 | 0.82 |
| 2018-06-30 | 0.38 |
| 2018-03-31 | 0.42 |
| 2017-12-31 | 0.48 |
| 2017-09-30 | 0.36 |
| 2017-06-30 | 0.69 |
| 2017-03-31 | 0.72 |
| 2016-12-31 | 0.79 |
| 2016-09-30 | 0.83 |
| 2016-06-30 | 1.14 |
| 2016-03-31 | 0.73 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.98 |
| 2015-06-30 | 2.16 |
| 2015-03-31 | 0.38 |
| 2014-12-31 | 0.57 |
| 2014-09-30 | 3.97 |
| 2014-06-30 | 6.00 |
| 2014-03-31 | 5.58 |
| 2013-12-31 | 0.18 |
| 2013-09-30 | 0.13 |
| 2013-06-30 | 0.19 |
| 2013-03-31 | 0.18 |
| 2012-12-31 | 0.22 |
| 2012-09-30 | 0.43 |
| 2012-06-30 | 0.64 |
| 2012-03-31 | 1.05 |
| 2011-12-31 | 1.25 |
| 2011-09-30 | 3.17 |
| 2011-06-30 | 0.11 |
| 2011-03-31 | 0.10 |
| 2010-12-31 | 0.02 |
| 2010-09-30 | 0.10 |
| 2010-06-30 | 0.09 |
| 2010-03-31 | 0.27 |
| 2009-12-31 | 0.15 |
| 2009-09-30 | 1.23 |
| 2009-06-30 | 12.48 |
| 2009-03-31 | 3.94 |
| 2008-12-31 | 3.29 |
| 2008-09-30 | 13.46 |
| 2008-06-30 | 13.67 |
| 2008-03-31 | 36.33 |
| 2007-12-31 | 35.07 |
| 2007-09-30 | 35.63 |
| 2007-06-30 | 4.02 |
| 2007-03-31 | 2.45 |
| 2006-12-31 | 3.78 |
| 2006-09-30 | 3.46 |
| 2006-06-30 | 3.86 |
| 2006-03-31 | 6.90 |
| 2005-12-31 | 4.12 |
| 2005-09-30 | 5.49 |
| 2005-06-30 | 3.45 |
| 2005-03-31 | 2.38 |
| 2004-12-31 | 1.91 |
| 2004-09-30 | 1.60 |
| 2004-06-30 | 3.25 |
| 2004-03-31 | 4.81 |
| 2003-12-31 | 5.45 |
| 2003-09-30 | 4.94 |
| 2003-06-30 | 4.28 |
| 2003-03-31 | 5.22 |
| 2002-12-31 | 4.56 |
| 2002-09-30 | 4.22 |
